Type 1 Diabetes, Progress With Stem Cells And Other Cell-Based Therapies

Novo Nordisk focuses on delaying the onset of Type 1 diabetes while paying attention to advances in stem cell technologies. Remarkable progress has been made in the treatment of Type 1 diabetes, which formerly was invariably fatal in young adults.

http://ift.tt/1FaqFy6